524400 — Ishita Drugs And Industries Balance Sheet
0.000.00%
Last trade - 00:00- IN₹227.65m
- IN₹160.48m
- IN₹146.60m
Annual balance sheet for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 84.8 | 65.5 | 78.7 | 83.5 | 68 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.75 | 20 | 7 | 21.4 | 17.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 100 | 102 | 96.6 | 150 | 95.4 |
| Net Property, Plant And Equipment | 8.85 | 8.89 | 8.05 | 8.79 | 26.3 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 113 | 114 | 108 | 163 | 126 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26.3 | 22.1 | 8.67 | 54 | 9.88 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.6 | 22.3 | 8.87 | 55.1 | 10.4 |
| Common Stock | |||||
| Other Equity | |||||
| Total Equity | 86 | 91.7 | 99.2 | 108 | 116 |
| Total Liabilities & Shareholders' Equity | 113 | 114 | 108 | 163 | 126 |
| Total Common Shares Outstanding |